Matthew J. Lawrence, Vanessa Evans, Janet Whitley, Suresh Pillai, Phylip R. Williams, James Coulson, . . . Phillip A. Evans. (2022). The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker. Wiley.
Chicago Style (17th ed.) CitationMatthew J. Lawrence, et al. The Effects of Apixaban on Clot Characteristics in Atrial Fibrillation: A Novel Pharmacodynamic Biomarker. Wiley, 2022.
MLA (9th ed.) CitationMatthew J. Lawrence, et al. The Effects of Apixaban on Clot Characteristics in Atrial Fibrillation: A Novel Pharmacodynamic Biomarker. Wiley, 2022.
Warning: These citations may not always be 100% accurate.